Introduction: A particular single nucleotide polymorphism (rs174547) was identified in the FADS1 gene according to published data, with significant association between its variants and the metabolism of fatty acids.
INTRODUCTION
Fatty acid desaturases (FADS) are membranebound key enzymes in the endogenous conversion of α-linolenic acid (ALA, C18:3n-3) and linoleic acid (LA, C18:2 n-6) into long-chain PUFAs (Poly Unsaturated Fatty Acids). D5D stands for delta-5 desaturase and D6D is delta-6 desaturase. These key enzymes are encoded by gene stermed FADS1 and FADS2 which are located in human chromosome 11 (11q12q13.1) separated by an 11 kb region Figure 1 (adaptation according to Linda Schaeffer et al (1) (2, 3) .There is also aFADS3 gene situated in the same cluster, but the function of its translated product remains unknown (4) . D5D and D6D are the rate limiting enzymes in the synthesis of long-chain PUFAs, arachidonic acid (AA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) from their dietary precursors LA and ALA. On the other hand AA and EPA are the precursor fatty acids for formation of eicosanoids and DHA for transformation into docosanoids.
D6D catalyzes the metabolic reaction of conversion of α-linolenic acid (ALA, 18:3n-3) and linoleic acid (LA, 18:2n-6) into stearidonic acid (STD, 18:4n-3) and γ-linolenic acid (GLA, 18:3n-6), respectively, Figure 2 (adapted to Lin Xie et al) (5) . Then an elongation step is performed, after which D5D introduces a double bond at the Δ5 position in the 20-carbon fatty acid chain. D5D catalyzes the conversion of eicosatetraenoic acid (ETA, 20:4n-3) and dihomo-γ-linolenic acid (DGLA, 20:3n-6) into eicosapentaenoic acid (EPA, 20:5n-3) and arachidonic acid (AA, 20:4n-6), respectively (6, 7)(2), Above mentioned PUFAs serve as important precursors for lipid-derived modulators of cell signaling, gene expression and inflammatory processes (8) . Irregularities in membrane fatty acid compositions have been associated with several chronic non-communicable human diseases such as autoimmune disorders (9) , coronary heart disease (10), cancer (8) , atopic eczema (11) and Alzheimer's disease (12) . Furthermore, D5D and D6D participate in the major metabolic pathway for synthesis of pro-inflammatory and antiinflammatory eicosanoids. Eicosanoids produce a wide range of biological effects on inflammatory responses (predominantly those of the joints, skin and eyes), on the intensity and duration of pain and fever, and on reproductive function (including the induction of labor) (13) (14) . They also play important roles for inhibition of gastric acid secretion, regulation of blood pressure through vasodilatation or constriction, and inhibition or activation of platelet aggregation and thrombosis. The principal eicosanoids of biological significance to humans are a group of molecules derived from the C20 fatty acid, arachidonic acid. Additional biologically significant eicosanoids are derived from dihomo-γ-linolenic acid which is produced in the reaction pathway transforming linoleic acid to arachidonic acid, Figure 2 . Minor eicosanoids are derived from eicosapentaenoic acid which is itself The FADS1 and FADS2 gene cluster involved in the metabolic pathway of LA and ALA are polymorphic. Recent studies on the polymorphism therein indicate that minor alleles of the genetic variants in FADS1and FADS2 are associated with higher levels of LA and lower AA levels in red blood cell membrane and plasma phospholipids that may influence the estimation of dietary requirements for prevention and for treatment purposes.
Studies on genetic variants and diet are called nutrigenetics, defined as the inherited basis for individual differences to nutrient (diet) response, whereas studies on the role of nutrients in gene expression are called nutrigenomics (15) .
Some studies in the nutrigenetics field have shown that blood concentrations of LDLcholesterol, HDL-cholesterol and triglycerides(TG) have a strong genetic influence (16)(17). Single nucleotide polymorphisms (SNPs) of the FADS gene cluster that includes FADS1, FADS2 and FADS3 genes, are associated with LDL, HDL, TG (18)(19) (20)and even with levels of fasting blood glucose concentrations (20) (21) . A relationship between these blood markers and the FADS1 polymorphism rs174547 (T/C) has been demonstrated in several studies (19, 20) . Moreover, this association between genetic variations in FADS1 and LDL could be modified by the intake of dietary long-chain PUFAs (22) . Hellstrand et al. observed significant interaction between variants of rs174547 and long-chain ω-3 PUFA intakes on LDL (P=0.01); they report that the C-allele was only associated with lower LDL among individuals in the lowest tertile of long-chain ω-3 PUFA intakes (P<0.001). In addition, significant interaction was observed between variants ofrs174547 and the ratio of ALA and linoleic FA intakes on HDL (P=0.03). However, no significant associations between the C-allele and HDL were determined within the intake tertiles of the ratio.
Perturbations in lipid metabolism characterize many of the chronic diseases currently affecting our modern society, such as cardiovascular diseases, type 2 diabetes, obesity, inflammation processes, alterations in the lipid status, etc. (6) . Lipids have very important structural and functional biological role in living organisms. Some lipids and their derivatives are main structural component of biological membranes, such as the cellular plasma membrane and the intracellular membranes of organelles. Triglycerides, stored in adipose tissue, are a major form of energy storage both in animals and plants. In the past 10-15 years, evidence has emerged showing that lipid signaling is a vital part of the cell signaling (23) (24) . Lipid signaling may occur via activation of G protein-coupled or nuclear receptors, and members of several different lipid categories have been identified as signaling molecules and cellular messengers. Lipids and their derivatives are also involved in membrane permeability, the process of inflammation and proliferation, immunity status and response (13, 25, 26) . Still, it remains unclear whether changes in lipid metabolism are the real cause or simply a consequence from the development of chronic diseases. However, changes in lifestyle or medical interventions in order to modify lipid levels are still the first goal to be achieved for health management and prevention.
OBJECTIVE
This study aimed to develop and verify methodology for detection and analysis of FADS1rs174547 genetic variants among the Bulgarian population.
Using the proposed methodology once detected and determined the rs174547 SNP could provide valuable information concerning individual's fatty acid metabolism and may support nutritionists when nutritional requirements for omega-3 and omega-6 fatty acids are estimated. Second, if applied at a large scale, this methodology could give researchers a tool to obtain epidemiological data concerning the genetic distribution of the particular SNP among Bulgarian population, which is to be done for the first time in Bulgaria.
METHODS

Study group
A small-scale group of 10 Bulgaria volunteers (aged 28-65) was randomly picked for the pilot study. All volunteers were acquainted with the procedure and signed informed consent paper. A buccal swab sample was collected from the inside of the cheek and placed in 200μl PBS buffer for further DNA extraction.
DNA extraction procedures
DNA extraction was performed using Gene GET Genomic DNA Purification Kit (Thermo Fisher Scientific, Cat.No:K0721) from buccal swab samples, according to the manufacturer's recommendation. Quality and quantity of the extracted nucleic acid were assessed both with a spectrophotometer and an agar gel electrophoresis. Buccal swab tissue was used as a sample material mostly because of the quality of the DNA that is harvested and because of the non-invasiveness of the procedure.
Primer design software
Primer 3 designer software was used (http:// biotools.umassmed.edu/bioapps/primer3_www. cgi). The technique requires input of human partial genomic sequence, Figure 3 , obtained from dbSNP genome database (http://www.ncbi.nlm.nih.gov/ snp/) by accession number of the targeted SNP (rs174547). Several parameters were determined when the primer set was generated, such as: the size of the amplicon; the content of GC; etc. When the primer set design was completed a report was generated with detailed information for each primer couple. Several sequences were chosen for synthesis and best initial results were obtained with a primer pair named FADS1-F and FADS1-R. The chosen specific primer set for the targeted SNP region, amplified a 243 bp DNA sequence. One primer consisted of 20 bp with the following sequence:
CACTCCCTTCACATGGTT GC; and the other also of 20 bp, with a given sequence: GGTTCCTGGAAAGCAACTGG, Table 1 .
PCR optimization process
Several parameters such as primer concentration, reaction temperatures and times were optimised in the polymerase chain reaction (PCR). Best PCR amplification was obtained with the following protocol: 5 min at 95 o C, followed by 40 cycles of denaturation (30 sec at 94 o C); annealing (30 sec at 56.5 o C) and extension (30 sec at 72 o C). All PCR reactions were run on Gene Amp® PCR system 9700 (Applied Biosystems). The reaction volume was 25μl, and the mixture contained 12.5μl TaqMan® Universal PCR Master Mix (cat.No4304437), 1μl of FADS1-F primer (10pmol/μl), 1μl of FADS1-F primer (10ρmol/μl), 5.5μl RNase/DNase Free water (Ferments) and 5μl diluted DNA sample. All reactions were conducted in the presence of two negative controls: 1. RNase/ DNase Free water (Non-template control, NTC); 2. Bacterial DNA.
Amplification products with the targeted C/T SNP inside were visualized after 40 min electrophoresis on a 2% agar gel stained with ethidium bromide, using 6x Orange Loading Dye® and 100 bp DNA Ladder (Ferments). Following the electrophoresis, agar gels were documented with the CN-1000 Dark Room Chemiluminescence Imaging System using Bio Capt software ver.12.5.
Sequencing reactions
Last, but not least, the specificity of the obtained products was verified through Sanger sequencing (ABI3730 XL capillary sequencer).The obtained data was read with the MEGA5 software, a consensus alignment was created and C/T polymorphism was determined for each sample, Figure 5 . 
RESULTS AND DISCUSSION
It was shown that under the optimized reaction condition the designed primer system by us produced an amplicon with the expected size (243bp) and contained a fragment from the FADS1 gene, with the analyzed C/T SNP inside.
The results from the agars gel electrophoresis show very discriminative illuminating band as PCR product located between 200 and 300 bp compared with the molecular marker. There are other bands that can be seen on the agar gel between 100 and 200 bp, indicating the presence of other PCR product with smaller molecular mass than the targeted one. However, the quality of the aimed product is not compromised, concluding from the strength of the signal from the Chemiluminescence Imaging System.
It was demonstrated that the designed FADS1 pair of primers are specific and reliable . Results from Sanger DNA Sequencing. The presented figure is part of the consensus alignment. S1 to S10 are the examined samples; rs174547 is human partial genomic sequence obtained from dbSNP genome database. In the alignment sample S1 and S2 are heterozygous (C/T) both containing the C variant and T allelic variant. tool for obtaining the targeted amplicon. The following sequencing by Sanger revealed the exact nucleotide variation, classifying the unknown samples as homozygote (samples having only allele C or allele T) and heterozygote (samples having both allele C and allele T). This information gives researchers vision of the magnitude of influence of the given SNP over the metabolic pathways and also has a predictive role for developing future chronic illnesses and conditions. But the science of nutrigenomic and nutrigenetics has definitely optimistic position about that knowledge and says that most of the negative consequences predicted by presence or absence of a particular SNP could be modified and affected by simple changes in the lifestyle and nutritional habits. This gives humanity another, proven by science, line of defense against developing future chronic diseases such as heart disease, type 2 diabetes, obesity, insulin resistance, Alzheimer's disease and other.
